JP2022553700A5 - - Google Patents
Info
- Publication number
- JP2022553700A5 JP2022553700A5 JP2022523558A JP2022523558A JP2022553700A5 JP 2022553700 A5 JP2022553700 A5 JP 2022553700A5 JP 2022523558 A JP2022523558 A JP 2022523558A JP 2022523558 A JP2022523558 A JP 2022523558A JP 2022553700 A5 JP2022553700 A5 JP 2022553700A5
- Authority
- JP
- Japan
- Prior art keywords
- phenyl
- carboxamide
- dihydro
- oxo
- benzodiazepine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB1915273.5 | 2019-10-22 | ||
| GB201915273A GB201915273D0 (en) | 2019-10-22 | 2019-10-22 | Pharmaceutical compounds |
| PCT/GB2020/052658 WO2021079121A1 (en) | 2019-10-22 | 2020-10-22 | Benzodiazepine derivatives for treating a respiratory syncytial virus (rsv) infection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022553700A JP2022553700A (ja) | 2022-12-26 |
| JP2022553700A5 true JP2022553700A5 (cg-RX-API-DMAC7.html) | 2023-10-23 |
| JP7667778B2 JP7667778B2 (ja) | 2025-04-23 |
Family
ID=68728299
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022523558A Active JP7667778B2 (ja) | 2019-10-22 | 2020-10-22 | 呼吸器合胞体ウイルス(rsv)感染症を治療するためのベンゾジアゼピン誘導体 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US20220409629A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4048665A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7667778B2 (cg-RX-API-DMAC7.html) |
| KR (1) | KR20220097420A (cg-RX-API-DMAC7.html) |
| CN (1) | CN114761397B (cg-RX-API-DMAC7.html) |
| CA (1) | CA3158169A1 (cg-RX-API-DMAC7.html) |
| GB (1) | GB201915273D0 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021079121A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201911944D0 (en) | 2019-08-20 | 2019-10-02 | Reviral Ltd | Pharmaceutical compounds |
| GB201915932D0 (en) | 2019-11-01 | 2019-12-18 | Reviral Ltd | Pharmaceutical compounds |
| GB202010409D0 (en) | 2020-07-07 | 2020-08-19 | Reviral Ltd | Pharmaceutical compounds |
| WO2024252355A1 (en) | 2023-06-08 | 2024-12-12 | Pfizer Inc. | Pediatric dosing regimens comprising a fusion inhibitor for the treatment of rsv |
| WO2025120500A1 (en) | 2023-12-06 | 2025-06-12 | Pfizer Inc. | Benzodiazepine compounds as n-protein inhibitors |
| CN122580320A (zh) | 2024-01-16 | 2026-08-14 | 辉瑞大药厂 | 作为n-蛋白抑制剂的苯二氮䓬吡唑甲酰胺类 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BR0314595A (pt) * | 2002-09-20 | 2005-08-09 | Arrow Therapeutics Ltd | Uso de um derivado de benzodiazepina ou um sal farmaceuticamente aceitável deste, inalador ou nebulisador, produto, usos de um produto e de um composto ou sal farmaceuticamente aceitável deste, derivado de benzodiazepina, composto, e, composição farmacêutica |
| GB0221923D0 (en) * | 2002-09-20 | 2002-10-30 | Arrow Therapeutics Ltd | Chemical compounds |
| GB0406280D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Chemical compounds |
| GB0406282D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Therapeutic compounds |
| US20070293482A1 (en) * | 2004-03-19 | 2007-12-20 | Novartis Pharmaceuticals Corporation | Process for Preparing Benzodiazepines |
| GB0406279D0 (en) * | 2004-03-19 | 2004-04-21 | Arrow Therapeutics Ltd | Therapeutic compounds |
| CA2622592A1 (en) * | 2005-09-19 | 2007-03-29 | Arrow Therapeutics Limited | Benzodiazepine derivatives for treating hepatitis c infection |
| US8871756B2 (en) * | 2011-08-11 | 2014-10-28 | Hoffmann-La Roche Inc. | Compounds for the treatment and prophylaxis of Respiratory Syncytial Virus disease |
| GB201506448D0 (en) | 2015-04-16 | 2015-06-03 | Univ Durham | An antimicrobial compound |
| MY197231A (en) * | 2015-07-22 | 2023-06-06 | Enanta Pharm Inc | Benzodiazepine derivatives as rsv inhibitors |
| GB201613942D0 (en) | 2016-08-15 | 2016-09-28 | Univ Of Durham The | An antimicrobial compound |
| WO2018129287A1 (en) | 2017-01-06 | 2018-07-12 | Enanta Pharmaceuticals, Inc. | Heteroaryldiazepine derivatives as rsv inhibitors |
| WO2018226801A1 (en) | 2017-06-07 | 2018-12-13 | Enanta Pharmaceuticals, Inc. | Aryldiazepine derivatives as rsv inhibitors |
| WO2020190935A1 (en) * | 2019-03-18 | 2020-09-24 | Enanta Pharmaceuticals, Inc. | Benzodiazepine derivatives as rsv inhibitors |
| GB201911944D0 (en) * | 2019-08-20 | 2019-10-02 | Reviral Ltd | Pharmaceutical compounds |
-
2019
- 2019-10-22 GB GB201915273A patent/GB201915273D0/en not_active Ceased
-
2020
- 2020-10-22 KR KR1020227017188A patent/KR20220097420A/ko not_active Ceased
- 2020-10-22 EP EP20800253.5A patent/EP4048665A1/en not_active Withdrawn
- 2020-10-22 US US17/770,455 patent/US20220409629A1/en not_active Abandoned
- 2020-10-22 CN CN202080082952.6A patent/CN114761397B/zh active Active
- 2020-10-22 JP JP2022523558A patent/JP7667778B2/ja active Active
- 2020-10-22 CA CA3158169A patent/CA3158169A1/en active Pending
- 2020-10-22 WO PCT/GB2020/052658 patent/WO2021079121A1/en not_active Ceased